FDA Approves Libtayo® for Locally Advanced and Metastatic Basal Cell CarcinomaThe U.S. Food and Drug Administration has approved Libtayo® (cemiplimab-rwlc) to treat certain types of locally advanced (cannot be removed by surgery) and metastatic (has spread) basal cell carcinoma (BCC)...reactionscomments
American Cancer Society Releases 2021 Report on CancerThe American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the...reactionscomments
COVID-19 Risks for People with CancerEditor’s Note: This article was first published on August 20, 2020. Further developments in what we know about the coronavirus are continuously emerging. Cancer and its treatments can weaken the...reactionscomments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...reactionscomments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...reactionscomments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...reactionscomments
COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one...reactionscomments
What to Know About Cancer and COVID-19 (Coronavirus)The spread of the novel coronavirus, COVID-19, has changed our daily lives. But people with a higher risk for illness from COVID-19 are wondering what they can do to stay...reactionscomments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic...reactionscomments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...reactionscomments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...reactionscomments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...reactionscomments
The American Cancer Society Issues 2020 Report on CancerThe American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017...reactions1comment
Take the Chronic Pain In America Survey! (Now Closed)This survey is now closed. Thank you to all our participants!We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with...reactionscomments
FDA Approves Keytruda for Advanced or Metastatic Merkel Cell CarcinomaThe U.S. Food and Drug Administration (FDA) has granted approval for Keytruda (pembrolizumab) as a treatment for advanced or metastatic Merkel cell carcinoma in both adults and children.Merkel cell carcinoma...reactions2comments
FDA Approves Immunotherapy Drug Libtayo for Advanced Cutaneous Squamous Cell CarcinomaOn September 28, 2018, the U.S. Food and Drug Administration (FDA) approved Libtayo (cemiplimab-rwlc) for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC). This approval is...reactionscomments
Melanoma Monday: The Today Show Tries to Break Guinness World RecordOn Monday, May 7th, the Today Show is going to try to break the Guinness World Record for “Most people applying sunscreen simultaneously.” The current record is 1,822 people, and...reactionscomments
Skin Cancer and Sun Protection for FirefightersIn February 2018, researchers from the "Firefighter Cancer Initiative" published new information about the risk of skin cancer for firefighters. According to this research, firefighters may have a higher risk...reactionscomments
New Test Approved Can Detect Multiple Genetic Mutations in CancerThe U.S. Food and Drug Administration (FDA) has approved a new genetic test that can detect 324 different genes that are known to be involved in 5 different cancer types:...reactionscomments
Using a Personalized Cancer Vaccine Against MelanomaResults from a new pilot study provide encouraging results on the use of a personalized cancer vaccine against melanoma. (A pilot study is an experiment conducted in a small group...reactionscomments
